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ABSTRACT: Stroke is the second leading cause of death worldwide. The prognostic influence of body temperature 
on acute stroke in patients has been recently reported; however, hypothermia has confounded experimental results in 
animal stroke models. This work aimed to investigate how body temperature could prognose stroke severity as well 
as reveal a possible mitochondrial mechanism in the association of body temperature and stroke severity. 
Lipopolysaccharide (LPS) compromises mitochondrial oxidative phosphorylation in cerebrovascular endothelial cells 
(CVECs) and worsens murine experimental stroke.  In this study, we report that LPS (0.1 mg/kg) exacerbates stroke 
infarction and neurological deficits, in the mean time LPS causes temporary hypothermia in the hyperacute stage 
during 6 hours post-stroke. Lower body temperature is associated with worse infarction and higher neurological 
deficit score in the LPS-stroke study. However, warming of the LPS-stroke mice compromises animal survival. 
Furthermore, a high dose of LPS (2 mg/kg) worsens neurological deficits, but causes persistent severe hypothermia 
that conceals the LPS exacerbation of stroke infarction. Mitochondrial respiratory chain complex I inhibitor, rotenone, 
replicates the data profile of the LPS-stroke study. Moreover, we have confirmed that rotenone compromises 
mitochondrial oxidative phosphorylation in CVECs. Lastly, the pooled data analyses of a large sample size (n=353) 
demonstrate that stroke mice have lower body temperature compared to sham mice within 6 hours post-surgery; the 
body temperature is significantly correlated with stroke outcomes; linear regression shows that lower body 
temperature is significantly associated with higher neurological scores and larger infarct volume. We conclude that 
post-stroke body temperature predicts stroke severity and mitochondrial impairment in CVECs plays a pivotal role 
in this hypothermic response. These novel findings suggest that body temperature is prognostic for stroke severity in 
experimental stroke animal models and may have translational significance for clinical stroke patients - targeting 
endothelial mitochondria may be a clinically useful approach for stroke therapy. 
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Stroke is the second leading cause of death and the leading 
cause of disability worldwide [1]. The prognostic 
influence of body temperature on acute stroke in patients 
has been recently reported [2]. Animal models of ischemic 
stroke are indispensable tools to investigate the 
pathophysiological mechanisms involved in ischemic 
brain injury and to develop novel therapies for stroke [3]. 
Temperature management is an important topic for 
experimental animal studies in stroke. In rodents, external 
warming resulted in aggravated neuronal damage 
following ischemia [4], and controlled-hypothermia 
robustly protects stroke outcomes after permanent and 
transient cerebral ischemia [5]. However, hypothermia 
has confounded experimental results in stroke [6], 
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becuase it is unclear how body temperature is associated 
with stroke severity in animal models of experimental 
stroke, and the mechanisms are poorly understood.    
Mitochondria play a pivotal role in cellular 
bioenergetics and cell survival, participating in a variety 
of cellular processes including generation of ATP, 
maintenance of body temperature, and regulation of 
apoptotic and other signaling pathways [7]. Mitochondrial 
damage has been documented in ischemic stroke patients 
[8, 9] and experimental stroke models [10, 11]. Our recent 
study demonstrates mitochondrial dysfunction opens the 
blood-brain barrier (BBB) in both in vitro and in vivo 
models and controls BBB permeability in acute 
experimental stroke in mice [12].  
Lipopolysaccharide (LPS), a major component of 
gram-negative bacteria cell wall, is broadly used as a 
bacterial infection mimic to induce a systemic 
inflammatory response [13]. LPS compromises 
mitochondrial oxidative phosphorylation in 
cerebrovascular endothelial cells and worsens murine 
experimental stroke [12]. High doses of LPS induce 
hypothermia [14, 15] and have been used in animal 
models of sepsis [16], but the mechanism by which LPS 
induces hypothermia is controversial [17]. 
Here, we studied LPS-exacerbated stroke and 
induced hypothermia, and investigated the relationship 
between body temperature and stroke outcomes in murine 
experimental stroke models. Inhibition of mitochondria 
with rotenone also exacerbated stroke outcomes and 
induced hypothermia after transient middle cerebral artery 
occlusion (tMCAO). Rotenone compromised 
mitochondrial oxidative phosphorylation in CVECs. 
Lastly, we pooled the data analyses from a large sample 
size (n=353) of body temperature and stroke outcomes 
and observed a strong negative linear regression between 
body temperature and stroke severity. These data suggest 
body temperature is useful for prediction of stroke 
severity in experimental animal stroke models and 
translation of significance in clinical stroke patients and 
may provide support for a clinically useful approach by 
targeting endothelial mitochondria for stroke therapy. 
 
 
 
 
 
 
 
Figure 1. Low-dose LPS causes temporary hypothermia, and the body temperature is correlated with stroke outcomes. (A) 
Scheme of the experimental design. LPS (0.1 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30 min prior to right tMCAO (30 
min occlusion) or sham and 48 hour reperfusion was performed. (B) Representative TTC-stained coronal sections from mice treated 
with vehicle or LPS (0.1 mg/kg), followed by 30 min tMCAO and 48 hours reperfusion. (C) Neurological deficits at 6 hours after 
tMCAO. Vehicle=18, LPS=23; data are expressed as mean ± S.D. ****, P<0.0001; Student’s t test. (D) Body temperature was recorded 
pre-treatment (PT), pre-surgery (PS), during surgery (S) and at 6, 12, 18, 24 and 48 hours. Data are expressed as mean ± S.D.; ****, 
P<0.0001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test. (E) Body temperature at 6 hours post-tMCAO is 
correlated with % cortex, striatum, and hemisphere infarction in 14 mice of the LPS (0.1 mg/kg) cohort of stroke study. (F) Body 
temperature at 6 hours post-tMCAO is correlated with neurologicial score in 41 mice of the LPS (0.1 mg/kg) cohort of stroke study. 
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Figure 2. Rewarming worsens LPS-stroke mice and compromises animal survival. (A) External warming worsened neurological 
deficits of LPS-tMCAO mice at 6 hours reperfusion. Room temperature (RT) n = 23, 37°C warm blanket (WB) n= 6; data are expressed 
as mean ± S.D. ***, P<0.001; Student’s t test. (B) External warming compromised survival of LPS-tMCAO mice. LPS (0.1 mg/kg, ip) 
was administered prior to right tMCAO (30 min occlusion). Post-stroke mice were housed at room temperature (RT, n=23) or placed 
on warm blanket (37°C, n=6). Chi square was used for statistical analysis of the survival rate. 
 
MATERIALS AND METHODS 
Mice 
All procedures conducted were approved by the 
Institutional Animal Care and Use Committees (IACUC) 
at the West Virginia University (WVU). Male mice with 
a C57/BL6J background (3-6 months old, 25-30g, 
Jackson Laboratories) were used for all studies. 
Murine experimental stroke models 
Surgical anesthesia was induced with 4-5% isoflurane and 
maintained with 1-2% isoflurane via face-mask in 
oxygen-enriched air. We performed focal cerebral 
ischemia by transient middle cerebral artery occlusion 
(tMCAO) or permanent middle cerebral artery occlusion 
(pMCAO) with a 6.0 monofilament suture (Doccol, 
Sharon, Massachusetts). We used laser Doppler 
flowmetry (Moor instruments, United Kingdom) to detect 
regional cerebral blood flow and confirm a successful 
occlusion (>70% decrease in flow). Rectal body 
temperature was maintained at 37 ± 0.5 °C during surgery. 
Randomized controls were used under a common protocol 
that collectively assessed 353 mice, including 42 mice 
with sham surgery, 40 mice with pMCAO, and 271 mice 
with tMCAO. All surgeries were performed by one 
surgeon who was blinded to pre-treatments. Neurological 
deficits of 311 stroke mice were recorded at 6-hour, 24-
hour, and 48-hour end points. Infarct volume of 162 stroke 
mice was determined at 24-hour or 48-hour end points 
using 2,3,5-triphenyl-2H-tetrazolium chloride (TTC; 
Sigma) staining. 
Evaluation of neurological deficits 
Neurologic deficits were determined according to a 0-5 
point scale of neurological score system as published [18]. 
0 = no neurological dysfunction; 1 = failure to extend left 
forelimb fully when lifted by tail; 2 = circling to the 
contralateral side; 3 = falling to the left; 4 = no 
spontaneous walk or in a comatose state; 5 = death. The 
experimenters were blinded to group allocations.  
Drug administration 
Administration of drugs by intraperitoneal (i.p.) injection 
was used. The doses of LPS or rotenone were described 
in Results section and figure legends. 
Post-surgery temperature management 
Mice were housed at room temperature (22 - 24 °C) after 
stroke or sham surgery. Rectal temperature was measured 
with a rectal probe thermometer (Thermoworks, Apline, 
UT). External warming (37 °C warm blanket) was applied 
to post-stroke mice in one study (Figure 2). 
Oxygen Consumption Rate detected by Bioscience 
Analyzer 
Cell culture was detailed previously [12]. Oxygen 
consumption rate (OCR) was measured at 37 °C using an 
XF96e extracellular analyzer (Seahorse Bioscience, North 
Billerica, Massachusetts) according to the manufacturer’s 
instructions. Briefly, the cerebrovascular endothelial cells 
(bEnd.3 cell line) were seeded into Seahorse Bioscience 
XF96e cell culture plates (16,000 cells/well). After 
overnight culture in the 37 °C humidified incubator with 
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5% CO2, the cells were supplied with medium rotenone 
(concentrations indicated in Figure 7) and cultured for 
additional 24 hours. For the OCR measurements, the 
medium was changed 1 h prior to the start of the 
extracellular flux assay to un-buffered (pH 7.4) DMEM 
containing 2 mM GlutaMax, 1 mM sodium pyruvate, and 
25 mM glucose and incubated at 37°C without CO2. 
Oligomycin, carbonyl cyanide 4-(trifluoromethoxy) 
phenylhydrazone (FCCP), rotenone and antimycin A (all 
from Sigma) of 10× compound dilutions were prepared 
for the assay. A sensor cartridge was loaded, calibrated 
and equilibrated, and then the protocol was implemented 
on an XF96e Analyzer. This protocol allowed 
determination of the basal level of oxygen consumption, 
the amount of oxygen consumption linked to ATP 
production, the maximal respiration capacity, and the 
non-mitochondrial oxygen consumption.  
 
 
Figure 3. High-dose LPS causes persistent hypothermia, worsens neurological deficits and results in immatured 
brain infarction. (A) Scheme of the experimental design. LPS (2 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30 
min prior to right tMCAO (30 min occlusion) and 24 hour reperfusion was performed. (B) Neurological deficits at 24 hours 
after tMCAO. N=4 per group; data are expressed as mean ± S.D. *, P<0.05; Student’s t test.  (C) Representative TTC-
stained coronal sections from mice treated with vehicle or LPS (2 mg/kg), followed by 30 min tMCAO and 24 hours 
reperfusion. Blue arrow indicated immatured infarction by TTC-staining. (D) Body temperature was recorded pre-treatment 
(PT), pre-surgery (PS), during surgery (S) and at 6, 12, 18 and 24 hours. Data are expressed as mean ± S.D.; ****, 
P<0.0001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test.  
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Statistics 
Comparisons of temperature were carried out by 2-way 
ANOVA, followed by post-hoc Sidak’s multiple 
comparison tests using Graphpad Prism software 
(Graphpad software, La Jolla, California). Student’s t tests 
were used in analyses of statistical differences of 
neurological deficits between two groups. Comparisons 
of OCR were carried out by 1-way ANOVA followed by 
post-hoc Tukey’s multiple comparison tests. Pearson’s 
correlation and linear regression were used in analyses of 
the relationship between body temperature and stroke 
outcomes. Pearson’s r value was used to establish a 
relationship: -0.01 to -0.19, no or negligible relationship; 
-0.20 to -0.29, weak negative relationship; -0.30 to -0.39, 
moderate negative relationship; -0.40 to -0.69, strong 
negative relationship; -0.70 or higher, very strong 
negative relationship. P<0.05 was considered significant. 
 
 
 
Figure 4. Rotenone decreases body temperature dose-dependently. (A) Scheme of the experimental design. Rotenone (i.p.) or 
vehicle (saline, i.p.) was administered and rectal temperature was recorded prior to treatment (PT), and at 6 and 24 hours. (B) Rotenone 
decreased rectal temperature in a dose-dependent manner. Data are expressed as mean ± S.D.; *, P<0.05, ****, P<0.0001; 2-way 
ANOVA followed by post-hoc Sidak’s multiple comparisons test. 
 
RESULTS 
 
LPS exacerbates stroke outcomes and causes prognostic 
hypothermia in stroke 
 
We have previously reported that LPS compromises 
endothelial mitochondria and worsens stroke severity [12]. 
We applied the same study protocol as published [12] and 
recorded the rectal temperature as pictured in Figure 1A. 
LPS administration plus stroke exacerbated infarction 
(Figure 1B) and neurological deficits at 6 hours (Figure 
1C). However, we observed that rectal temperature was 
significantly decreased by LPS administration plus stroke 
within 6 hours after injection and partially recovered after 
12 hours (Figure 1D). We then performed a correlation 
analysis between body temperature and stroke outcomes. 
Interestingly, there were strong negative correlations 
between 6-hour body temperature and stroke outcomes 
including cortical infarction (r=-0.6976, P=0.0055) and 
total hemispheric infarction (r=-0.5992, P=0.0235) 
(Figure 1E), and neurological score (r=-0.6564, P<0.0001) 
(Figure 1F). Taken together, the data suggest that LPS 
exacerbates stroke outcomes and causes hypothermia, and 
the lower body temperature is a prognostic index of worse 
stroke. 
It is well known that hypothermia protects stroke 
outcomes after permanent or transient cerebral ischemia 
[5]. To further investigate whether hypothermia worsens 
or protects outcomes in the LPS-stroke study, an external 
warming was applied to the LPS-stroke animals. 
Surprisingly, the external warming worsened neurological 
deficits (Figure 2A) and compromised survival of LPS-
stroke mice such that all mice died within 8 hours post-
stroke (Figure 2B). The data suggest that hypothermia 
does protect stroke outcomes, such an observation that 
seems in conflict with the observation described in Figure 
1. 
We have shown that LPS compromises 
mitochondria in CVECs dose dependently [12]. To further 
elucidate the confounding relationship between body 
temperature and stroke outcomes, a high dose of LPS (2 
mg/kg) that induces hypothermia in mice [14, 15] was 
applied to mice following the protocol depicted in Figure 
3A. Interestingly, a high dose of LPS plus tMCAO 
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worsened neurological deficits (Figure 3B) but caused 
immatured stroke infarction, which showed pink staining 
using TTC (Figure 3C), and resulted in persistent severe 
hypothermia after tMCAO (Figure 3D). The data indicate 
that a high dose of LPS worsens stroke neurological 
deficits and leads to persistent severe hypothermia, which 
protects stroke infarction. 
 
 
 
 
 
 
 
 
Figure. 5. Low-dose rotenone causes hypothermia, and body temperature is correlated with acute stroke outcomes in mice. (A) 
Scheme of the experimental design. Rotenone (1 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30 min prior to right tMCAO 
(60 min occlusion) and 24 hour reperfusion was performed. (B) Representative TTC-stained coronal sections from mice treated with 
vehicle or rotenone (1 mg/kg), followed by 60 min tMCAO and 24 hours reperfusion. (C) Neurological deficits at 24 hours after 
tMCAO. N=12 per group; data are expressed as mean ± S.D. ****, P<0.0001; Student’s t test. (D) Body temperature was recorded 
pre-treatment (PT), pre-surgery (PS), during surgery (S) and at 6 and 24 hours. Data are expressed as mean ± S.D.; ****, P<0.0001; 
2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test. (E) Body temperature is correlated with neurologicial score 
in 24 mice of rotenone (1 mg/kg) cohort of stroke study. (F) Body temperature is correlated with % cortex infarction, striatum 
infarction, and hemisphere infarction in 16 mice in the rotenone (1 mg/kg) cohort of stroke study. 
 
 
Mitochondrial impairment in cerebrovascular 
endothelial cells is involved in post-stroke hypothermia  
 
Due to the key role of mitochondria in cellular 
bioenergetics and metabolisms, low body temperature has 
been considered a symptom of mitochondrial failure [19]. 
LPS impairs mitochondrial oxidative phosphorylation [12] 
and causes hypothermia (Figure 1 and 3). To further 
elucidate whether mitochondrial oxidative 
phosphorylation is involved in the body temperature 
change in acute stroke, we treated mice with rotenone (a 
mitochondrial respiratory chain complex I inhibitor) and 
monitored rectal temperature (Figure 4A). Rotenone 
alone dose-dependently decreased body temperature in 
vivo (Figure 4B).  In a study of the combination of 
rotenone and stroke, a low dose of rotenone (1 mg/kg), 
which did not induce hypothermia in naive mice (Figure 
4), exacerbated infarction (Figure 5B), worsened 
neurological deficits (Figure 5C), as well as resulted in 
significant hypothermia following 60 min tMCAO 
(Figure 5C). Correlational analysis showed very strong 
negative correlations between 6-hour body temperature 
and neurological score (r=-0.7452, P<0.0001, Figure 5E), 
cortical infarction (r=-0.7368, P=0.0011) and hemisphere 
infarction (r=-0.8213, P<0.0001), and strong negative 
correlations with striatum infarction (r=-0.6633, 
P=0.0051) (Figure 5F). These data are consistent with the 
findings in the low dose LPS-stroke study (Figure 1) and 
suggest that mitochondrial impairment is involved in the 
body temperature change in stroke. 
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Figure 6.  High-dose rotenone causes persistent hypothermia, worsens neurological deficits, and results 
in immatured brain infarction.  (A) Scheme of the experimental design. Rotenone (4 mg/kg, i.p.) or vehicle 
(saline, i.p.) was administered 30 min prior to right tMCAO (30 min occlusion) and 24 hour reperfusion was 
performed. (B) Neurological deficits at 24 hours after tMCAO. N=4 per group; data are expressed as mean ± 
S.D. **, P<0.01; Student’s t test. (C) Representative TTC-stained coronal sections from mice treated with 
vehicle or rotenone (4 mg/kg), followed by 30 min tMCAO and 24 hours reperfusion. Blue arrow indicates 
immature infarction from TTC staining. (D) Rectal temperature was recorded pre-treatment (PT), pre-surgery 
(PS), during surgery (S) and at 6 and 24 hours. Data are expressed as mean ± S.D.; ****, P<0.0001, ***, 
P<0.001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test.  
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Figure 7.   Rotenone compromises mitochondrial function in cultured cerebral vascular endothelial cells. (A) Raw data of oxgen 
consumption rate (OCR) determinied by the Seahorse XF96e analyzer.  Cultured cerebral vascular endothelial cells (bEnd3. cell line) 
were incubated with various concentration of rotenone for 24 hours then OCR was determined upon sequential exposure to oligomycin, 
FCCP, and rotenone/antimycin. (B) Analysis of the Seahorse data. Rotenone decreased basal respiration, oligomycin-sensitive ATP 
production, maximal respiration in the presence of FCCP, and spare capacity of cerebral vascular endothelial cells in a dose-dependent 
manner. N = 4 per group; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. One-way ANOVA followed by post-hoc Tukey’s 
test was used for statistical analysis.   
 
 
Interestingly, a high dose of rotenone (4 mg/kg), 
which induces hypothermia in naive mice (Figure 4), 
worsened neurological deficits following 30 min tMCAO 
(Figure 6B) but resulted in immatured stroke infarction by 
TTC-staining (Figure 6C) and also caused persistent 
severe hypothermia (Figure 6D), which replicated the 
results from the high dose of LPS plus tMCAO mice 
(Figure 3). Again, the data indicate that a high dose of 
rotenone worsens stroke neurological deficits and results 
in persistent severe hypothermia that is protective for 
stroke infarction. 
In order to identify whether rotenone affects 
cerebrovascular endothelial mitochondria, such as that 
LPS targets on CVECs in our previous report [12], a 
cerebrovascular endothelial cell culture model was 
employed and mitochondrial capacity was evaluated. We 
found that rotenone dose-dependently compromised 
mitochondrial oxidative phosphorylation in CVECs 
(Figure 7). Mitochondrial basal respiration, ATP 
production, maximal respiration, and spare capacity were 
all reduced in CVECs (Figure 7B).  These data suggest 
that CVECs are one of the cellular targets in the 
mitochondrial impairment. 
 
 
Body temperature predicts stroke outcomes  
 
To further investigate the relationships between body 
temperature and stroke outcomes, we pooled the data from 
353 mice, with 42 (11.9%) sham surgery, 271 (76.8%) 
tMCAO, 40 (11.3%) pMCAO on stroke outcomes. Before 
surgery, there was no significant difference between the 
body temperatures of treatment groups (Figure 8A). 
Stroke mice had lower body temperature compared to 
sham mice within 6 hours post-surgery (Figure 8A). We 
performed the correlation analyses and linear regression 
analyses respectively to address the relationship of 
neurological score and infarct volumes with rectal 
temperature recorded within 6 hours post-surgery. There 
were significant negative correlations between 6 hours 
post-surgery body temperature and neurological deficits, 
and all infarct volumes (cortex, striatum, or total 
hemisphere) after MCAO (Figure 8B and C). Linear 
regression with neurological score as the dependent 
variable showed that lower body temperature was 
significantly associated with higher neurological score at 
all end points (r=-0.5432, R2=0.2951, P<0.0001, Figure 
8B). Linear regression also showed significant 
associations between lower body temperature and larger 
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cortex infarct volume (r=-0.3476, R2=0.1208, P<0.0001), 
striatum infarct volume (r=-0.2782, R2 =0.07741, 
P=0.0003), and total hemisphere infarct volume (r=-
0.4124, R2=0.1701, P<0.0001) (Figure 8C). These data 
suggest that hypothermia is a common response to stroke 
and predicts worse stroke outcomes in murine 
experimental stroke. 
 
 
 
 
 
Figure 8. The relationship of body temperature and stroke outcomes in murine experimental stroke. (A) Stroke decreased 
body temperature. Rectal temperature was recorded pre-surgery (PS), during surgery (S), and within 6 hours post-surgery. Data are 
presented as mean ± S.D.; 2-way ANOVA followed by post-hoc Sidak's multiple comparisons test. ****, P<0.0001. (B) Body 
temperature is correlated with neurological score in 311 mice. (C) Body temperature is correlated with % cortex infarction, striatum 
infarction, and hemisphere infarction in 162 mice. 
 
 
DISCUSSION 
 
In this study, we investigated the relationship between 
body temperature and stroke outcomes in experimental 
stroke and revealed a mitochondrial mechanism in the 
hypothermic response to stroke. As summarized in Figure 
9, stroke, LPS, or rotenone causes endothelial 
mitochondria impairment in the acute stage, which 
increases BBB permeability and brain edema, then 
worsens stroke outcomes. However, compromised 
endothelial mitochondria also lead to hypothermia, which 
delays neuronal death and protects stroke infarction, and 
thus conceals some of the negative effects in stroke. 
Therefore, hypothermia is indicative of mitochondrial 
impairment in BBB endothelium and can be used to 
predict stroke severity in mice.  
Body temperature is one of the vital signs in 
monitoring medical problems. Recent clinical studies 
demonstrate that low body temperature within 6 hours of 
symptom onset is associated with severe ischemic stroke 
[2, 20] and severe stroke subjects have relatively low body 
temperatures at admission within 12 hours of symptom 
onset in human subjects [21]. In animal models of 
experimental stroke, it is well known that controlled-
hypothermia is a neuroprotectant and a potential treatment 
in cerebral ischemia via reduction of energy requirements 
in the brain and protect the brain from infarct formation 
[22, 23]. Barber et al. [24] observed that temperature in 
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mouse MCAO is important to stoke outcomes. Our data 
demonstrate a decrease in body temperature within 6 
hours in experimental stroke (Figure 8). Not only did 
LPS- or rotenone-pretreatments reduce body temperature 
in experimental stroke (Fig.1D, 3D, 5D and 6D), but also 
in naive mice, high doses of LPS or rotenone induced 
hypothermic responses within hours (Figure 3D and 4B).  
Thus, body temperature alterations may reveal previously 
unknown mechanism factors that contribute to stroke 
severity.  
 
 
 
 
 
 
 
 
Figure 9. Endothelial mitochondria and hypothermia are engaged in stroke outcomes. Stroke, LPS or rotenone compromises 
endothelial mitochondria in the acute stage. The mitochondrial impairment increases BBB permeability and brain edema, further 
worsens stroke outcomes. The mitochondrial impairment also leads to hypothermia, which is neuroprotective and protects stroke 
outcomes. Hypothermia is indicative of the mitochondrial capacity and therefore has prognostic effect on stroke outcomes. 
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It is known that mitochondrial oxidative metabolism 
is one of the homeostatic mechanisms used to generate 
heat for maintenance of body temperature. However, the 
thermoregulation is far more complex. Briefly, the 
vascular endothelium, smooth muscle cells, and nerve 
terminals form an integrated unit and regulate body 
temperature by preserving or releasing heat generated by 
mitochondrial activity in periphery and are coordinated by 
hypothalamus in central nervous system (CNS) [25]. 
Undoubtedly, the endothelium plays an important role in 
maintaining and regulating body temperature. Given the 
extensive expression of TLR4 (LPS receptor) on 
endothelial cells, hypothermia induced by high dose of 
LPS in sepsis model [26] or low dose of LPS plus tMCAO 
(Figure 1) may be due to compromised mitochondrial 
function in endothelial cells [12]. Rotenone decreased 
body temperature dose-dependently (Figure 4), 
compromised mitochondrial oxidative phosphorylation in 
cerebrovascular endothelial cells in vitro (Figure 3) and 
increased BBB permeability [12]. The observation of 
hypothermia in LPS-stroke mice (Figure 1 and 3) and 
rotenone-stroke mice (Figure 5 and 6), consistent with the 
temporal profile of BBB leakage at 6 hours post-stroke, 
indicates that compromised mitochondrial capacity in 
endothelium may not be able to maintain BBB integrity 
and normal body temperature, resulting in elevated BBB 
leakage and post-stroke hypothermia. Thus, 
mitochondrial mechanism may be one of the important 
factors of the hypothermic response to stroke. The data 
also suggest that the hypothermic response in severe cases 
of sepsis in animal studies and clinically may also be 
mitochondrial-dependent.   
It was observed that low doses of rotenone or LPS, 
which did not significantly alter body temperature in sham 
or naive mice (Figure 1D and Figure 4), caused robust 
hypothermia and exacerbated stroke outcomes (Figure 1D 
and 5D). Both LPS [12] and rotenone (Figure 7) impair 
endothelial mitochondria. Stroke induces mitochondrial 
failure and causes cell death [27]. The low dose of LPS- 
or rotenone may interact with stroke to further impair 
mitochondrial function and exacerbate stroke outcomes.  
It is well-known that hypothermia protects the brain 
from deleterious ischemic effects and our data also 
confirmed its neuroprotective effect in stroke. We found 
that external warming compromised survival of the 
hypothermic LPS-tMCAO mice (Figure 2). High doses of 
LPS (2 mg/kg, Figure 3) or rotenone (4 mg/kg, Figure 6) 
could be very toxic to brain tissue, while LPS- or 
rotenone-induced neurotoxicity is seen with local 
administration [28, 29]; however, large infarctions were 
not observed following the combination of high doses of 
LPS or rotenone and tMCAO. The observed hypothermia 
may have protected the brain by reducing the energy and 
oxygen demand of brain tissue and delayed cell death in 
the ischemic area. Functional outcomes demonstrate 
sensitive or earlier indication than pathological cell death, 
and thus, the worse neurological deficits, rather than the 
stroke infarction, were observed in severe hypothermic 
animals (Figure 3B and 6B).  
Interestingly, persistent post-stroke hypothermia 
resulted in immatured stroke infarction in the ischemic 
brain by TTC-staining and worse neurological deficits 
(Figure 3 and 6). These findings have been supported by 
other laboratories. Denes et al. [30] reported that LPS 
compromised survival and increased brain edema but not 
infarct size as assessed by crystal-violet staining; Moyer 
et al. [31] reported hypothermia during occlusion 
diminishes cerebral infarction in rats. Several groups have 
reported that NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo (F)quinoxaline), an α-amino-3-hydroxy-5-methyl-
4-isoxazole propionate antagonist, provides robust 
protection against neuronal loss in experimental stroke 
models [32-35]. However, Nurse and Corbett [36] have 
further verified that a hypothermic action is linearly 
related to the neuroprotective efficacy and NBQX is 
ineffective against cerebral ischemia when the body 
temperature was regulated to mimic that of the vehicle 
group. Taken together, the hypothermic response protects 
stroke infarction and may lead to false negative data in 
quantifying infarct size in experimental animal stroke 
studies. The false negative data could be reversed by 
extension of endpoints (Figure 1), lowering the dose of 
drugs (Figure 1 and 5), or inducing a larger injury (Figure 
5). Therefore, caution should be taken in the conclusion 
of infarct size changes using animal models of 
experimental stroke. 
Another important finding was the negative 
correlations between body temperature and stroke 
outcomes. In Figure 1, 5 and 8, the strong associations 
support that hypothermic animals have higher 
neurological deficits and larger infarction. The significant 
linear regression (Figure 8) indicates that stroke outcomes 
may be determined by body temperatures early after 
strokes. Even though the data were from pooled analyses, 
which might be affected by multiple factors, it does 
suggest that body temperatures may predict stroke 
outcomes. The mitochondria-dependent hypothermic 
response explains the correlation of hypothermia and 
stroke severity in vivo and the doubling of mortality rate 
in hypothermic sepsis patients [37].  In both disease states, 
induced hypothermia is thought to be protective; however, 
if hypothermia is a result of brain endothelial cell 
mitochondrial dysfunction, the association of 
hypothermia and exacerbated disease outcomes is not 
surprising because severe hypothermia indicates worse 
mitochondrial impairment in endothelium as described in 
Figure 9. These findings offer early clues on 
mitochondrial impairment in stroke and sepsis and offer a 
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translational significance in that mitochondrial protection 
could be used. 
The involvement of hypothalamic damage in post-
stroke thermoregulation has been reported [38].  In our 
study, only a few MCAO mice had visible hypothalamic 
injury (by TTC staining) with or without severe brain 
edema. In these few cases, injury to the hypothalamus 
may be caused by occlusion of hypothalamus arterial 
perforators, but also could be due to brain edema caused 
by BBB leakage. In view of the correlation between 
hypothermia and infarct volume as well as the rare 
occurrences of hypothalamic injury, we argue that the 
hypothermic response is due to mitochondrial impairment 
rather than the hypothalamic damage.  
LPS [39, 40] and rotenone [41, 42] are well-known 
to induce systemic hemodynamic alterations. LPS may 
reduce interendothelial coupling and arteriolar conduction 
and cause hemodynamic effects [43]. Rounds and 
McMurtry [44] demonstrated that inhibition of ATP 
production by rotenone decreases vasoconstriction, 
blocks subsequent pressor responses, and causes 
hemodynamic effects. Our data demonstrated that LPS 
[12] or rotenone (Figure 7) compromises endothelial 
mitochondrial oxidative phosphorylation. Mitochondria 
by themselves generate reactive oxidative species (ROS) 
during normal respiration, and some studies suggest that 
when the normal function of the electron transport chain 
is affected, ROS output may be augmented, thus 
increasing the oxidative burden of the cell and inhibit 
pressor responses [45, 46]. The hemodynamic effects 
could result from the compromised endothelial 
mitochondria and can potentially lead to body temperature 
decrease as well as worsen stroke outcomes. The 
hemodynamic responses could also be secondary effects 
resulting from the compromised mitochondria in line with 
previous report [47], and probably is indicative of stroke 
severity as well.  
Our study has several limitations. First, only young 
male mice and ischemic stroke models were used. Second, 
our stroke models produced large infarcts that more 
closely resemble malignant infarction than the average 
size of human strokes [48]. Third, we did not monitor 
post-stroke decline in spontaneous locomotor activity, 
which may affect body temperature. Addition of other 
species, multiple strains, different ages, both genders and 
multiple types of experimental stroke models along with 
long-term functional recovery are needed to firmly 
establish the relationship between post-stroke body 
temperature alterations and stroke outcomes. 
In summary, this study demonstrates a negative 
correlation between body temperature and stroke severity 
in animal models of experimental stroke, elucidates a new 
mitochondrial-dependent mechanism for hypothermic 
response in stroke, and suggests the need to protect 
endothelial mitochondria for stroke patients with 
hypothermia. 
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